Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Small. 2015 Nov 19;11(48):6458–6466. doi: 10.1002/smll.201502972

Bioorthogonal Click Chemistry-Based Synthetic Cell Glue

Heebeom Koo 1, Myunghwan Choi 2, Eunha Kim 3, Sei Kwang Hahn 4, Ralph Weissleder 5, Seok Hyun Yun 6,
PMCID: PMC5556392  NIHMSID: NIHMS860052  PMID: 26768353

Abstract

Artificial methods of cell adhesion can be effective in building functional cell complexes in vitro, but methods for in vivo use are currently lacking. Here, we introduce a chemical cell glue based on bioorthogonal click chemistry with high stability and robustness. Tetrazine (Tz) and trans-cyclooctene (TCO) conjugated to the cell surface form covalent bonds between cells within 10 min in aqueous conditions. Glued, homogeneous or heterogeneous cell pairs remain viable and stably attached in a microfluidic flow channel at a shear stress of 20 dyn/cm2. Upon intravenous injection of assembled Jurkat T cells into live mice, fluorescence microscopy showed the trafficking of cell pairs in circulation and their infiltration into lung tissues. Our results demonstrate the promising potential of chemically glued cell pairs for various applications ranging from delivering therapeutic cells to studying cell-cell interactions in vivo.

Keywords: click chemistry, metabolic glycoengineering, cell adhesion, tissue engineering, cell delivery

The table of contents

graphic file with name nihms860052u1.jpg

Bioorthogonal click chemistry-based cell glue enabled synthethic cell-cell adhesion with high stability and robustness. Tetrazine (Tz) and trans-cyclooctene (TCO) conjugated to the cell surface form covalent bonds between cells within 10 min in aqueous conditions. Glued cells remain viable and stably attached in blood flow. It has potential for biomedical applications ranging from delivering therapeutic cells to studying cell-cell interactions in vivo.

1. Introduction

Close contact between cells is essential to establish intercellular communication, exert collective functions, and form multicellular structures.[1] In nature, the contact interaction is typically achieved by a series of surface adhesion molecules and connections.[2] A synthetic method to control the contact and binding between cells would be useful in tissue engineering and cell therapy[3] by producing functional cell pairs and higher complexes.[4] A promising approach for artificial cell adhesion is to modify cell surfaces with high-affinity “glue” molecules. This has been demonstrated by using complementary nucleotide sequences[4a,5], avidin-biotin interaction,[6] antibody dimers,[7] and aptamers.[8] The complementary macromolecules can provide binding specificity for bottom-up assembly of multicellular, multidimensional units in vitro. A drawback of these non-covalent methods is their limited tensile strength and stability, particularly for in vivo use, which can be degraded by enzymes, such as proteases, DNases, and RNases.[8] In comparison, covalent chemical bonds using bioorthogonal small molecules (<1 kDa) offer compelling advantages. First, the chemical bonds are irreversible and therefore more stable and robust than biological bonds. Second, small chemicals can be introduced to the cell surface at higher density,[9] which can yield stronger, multivalent adhesion between cells. Furthermore, the cost for synthesis and storage can be considerably lower for chemicals than proteins and nucleotides. Recently, chemical binding of cells has been demonstrated by using oxime-hydroquinone chemistry, but this method required a long binding time of over 1 hour due to its slow reaction rate.[10]

Here, we introduce click chemistry for stable and robust cell gluing. Click chemistry has originally been referred to chemical reactions with high yield, simple reaction condition, and inoffensive byproducts.[11] Cycloaddition reaction between azide (N3) and alkyne groups with copper catalysts has been widely used. To date, several click-chemistry reactions including strained alkynes/azide and tetrazine (Tz)/trans-cyclooctene (TCO) have been developed, which occur in aqueous conditions without using toxic copper catalyst.[12] The ‘copper-free’ click chemistry has been widely used to attach individual molecules and nanoparticles for molecular assay,[13] targeted imaging,[14] and drug delivery.[15] Beyond attaching small molecules and nanoparticles, gluing macroscopic objects,[16] such as biological cells, poses significant challenge that requires more stringent optimizations in terms of the reaction rate and binding force, as well as biocompatibility. In this work, we have used a double click chemistry strategy for efficient and robust cell-cell gluing. Prior to attaching Tz and TCO molecules, cells have been modified first by metabolic glycoengineering, introducing azide groups onto the cell surface with minimal biological perturbations (Scheme 1).[17] Tz and TCO are then attached to the azide using azide-dibenzocyclootyne (DBCO) click chemistry via heterobifunctional crosslinkers, Tz-DBCO and TCO-DBCO (Figure S1, Supporting Information).[18] When mixed together, the Tz- and TCO-modified cells form a pair (Scheme 1). We have performed cell-binding force measurements and animal injection study to assess the potential of chemically glued cells for in vivo applications.

Scheme 1.

Scheme 1

Illustration of the cellular gluing method based on metabolic glycoengineering and double click chemistry. (Chemical structure was corrected)

2. Results and discussion

2.1. Gluing cells by metabolic glycoengineering and double click chemistry

We used four human and mouse cell lines—namely, A549 human lung cancer cells, human Jurkat T lymphocytes, NIH3T3 murine fibroblasts, and EL4 murine lymphoma cells. Cell viability after azide-modification showed a marked drop at concentrations of tetraacetylated N-azidoacetyl-d-mannosamine (Ac4ManNAz) higher than 60 µM (Figure S2a, Supporting Information). In all experiments otherwise stated, we used a nontoxic concentration of 50 µM. The subsequent treatment with Tz-DBCO or TCO-DBCO had little effect on cell viability at concentrations up to 100 µM (Figure S2b and S2c, Supporting Information). Fluorescence microscopy performed after conjugating Cy3 to the azide group in situ by administrating Cy3-DBCO showed the spatially uniform, high expression of the azide groups in A549 cells (Figure S3, Supporting information). Tz-Cy3 and TCO-Cy3 conjugates (Figure S4, Supporting Information) were used to measure the overall amount of TCO and Tz molecules on the cell surface (Figure S5–S8, Supporting Information). Among the four cell lines, Jurkat T and A549 cells had significantly higher incorporation than NIH3T3 cells, and EL4 cells showed the lowest incorporation (Figure 1a). The cell line-dependent incorporation of Tz and TCO was consistent with the known difference in the amount of sialic acids on the cell surface.[19]

Figure 1.

Figure 1

Analysis of viability and function of glued cells. (a) Measured amount of Tz and TCO groups on cell surface after chemical modification for four different cell lines. Error bars, s.d.; *, t-test P < 0.005 (sample n=10). (b) Illustration of cellular gluing between suspension (red) and adhesion (green) cells. (c) Fluorescence images of the glued cells in a microfluidic chamber after washing with a flow at 1 ml/mm. Scale bar, 50 µm (d) Viability of Jurkat-Jurkat glued cells measured using calcein AM/Ethidium homodimer 1 assay after incubation for 1 day in culture. (e) IL-2 secretion from glued Jurkat T cells. Error bars, s.d. (sample n=5). (f) Microscopic images showing the migration of NIH3T3 cells (green) carrying Jurkat T cells (red) glued on their surface. Scale bar, 100 µm.

2.2. Viability, IL-2 secretion, and migration of glued cells

We next investigated the viability of Jurkat T and A549 cells as glued pairs. A549 adhesion cells were grown on a microfluidic chamber in monolayer and modified with Tz as above. Jurkat T cells were modified with TCO and added on top of the Tz-modified A549 cell layer (Figure 1b). After 10 min of incubation for Tz-TCO reaction, Jurkat T cells were glued on to A549 cells. The glued cells showed no dissociation under the flow at a rate of 1 ml/min (Figure 1c). By contrast, non-modified Jurkat T cells in control experiments were almost completely washed away in same condition (Figure 1c and Figure S9 in Supporting Information). Live/dead cell assays using calcein AM and Ethidium homodimer 1 showed that 93% of Jurkat T cells were alive within 1 hour after TCO modification. 85% of Jurkat T cells were alive at 1 hour after gluing to A549 cells, and 77% remained viable after further incubation in cell media for 24 hours (Figure 1d). Jurkat T cells secret interleukin-2 (IL-2) when stimulated by lectins. To test whether this intrinsic function is preserved after gluing, we administered 10 µg/ml phytohemaglutinin to Jurkat T glued on A549 cells and, after one day of incubation, measured the amount of secreted IL-2 by human IL-2 enzyme-linked immuno assay (ELISA). IL-2 secretion from Jurkat T cells was slightly, but insignificantly, decreased in the glued cells compared to unmodified cells (Figure 1e). The slight decrease in IL-2 secretion may originate from that their surface was partially covered by A549 cells, but the result indicates that the intrinsic function was largely unaffected.

We also investigated the migration function of NIH3T3 fibroblasts after gluing with Jurkat T cells grown on culture wells. After gluing, a cross scratch pattern was created for wound healing assay. After incubation for 1 day, NIH3T3 cells were found to have migrated into the scratched area (Figure 1f). A significant fraction of the migrated NIH3T3 cells had one or two Jurkat T cells associated with them. This result not only shows the mobility of glued cell pairs but also suggests the potential of a cell delivery strategy by gluing a cargo cell to a mobile carrier cell.

2.3. Microfluidic measurement of the binding force between glued cells

To measure the binding force between glued cells, we used flow-induced shear in the microfluidic channel (5 mm in width and 0.8 mm in height) and measured the number of suspension cells attached on adhesion cells (Figure 2a). TCO-modified Jurkat T cells glued onto Tz-modified A549 cells remained attached after applying flow for 1 min at flow rates up to 60 ml/min, the maximum available tested (Figure 2b). Similar results were obtained for Jurkat T cells glued on NIH3T3 cells (Figure S10 in Supporting Information). The shear stress exerted on the cells was calculated to be about 20 dyn/cm2 (2 Pa) at 60 ml/min.[20] The ratios of the remaining Jurkat T cells to A549 cells were 1.05 at 10 min after gluing and 0.75 after incubation for 24 hours in full growth medium containing serum (Figure 2c). The ratio was 0.61 at Day 2, indicating that more than half of the glued cells remained bound to A549 cells (Figure S11 in supporting information). Similar ratios, 1.0 at Day 0 and 0.65 at Day 1, were measured for Jurkat T and NIH3T3 cells (Figure 2d). The ratios were significantly lower for EL4 cells compared to Jurkat T (0.18 per A549 cell) (Figure S12 in Supporting Information). The lowest ratio of 0.07 was obtained with EL4 on NIH3T3 cells. These results are consistent with the measured amount of Tz and TCO molecules for those cell types (Figure 1a). The more Tz and TCO groups are available on the cell surface, the more cell pairs are produced, resulting in the greater binding force.

Figure 2.

Figure 2

Analysis of the binding force between glued cells. (a) Illustration of the flowing test on the glued cells in microfluidic chambers. (b) Fluorescence images of the glued Jurkat T cells on A549 cells. Scale bar, 50 µm. Flow at 60 ml/min was applied for duration of 1 min, at 10 min (Day 0) and 24 hours (Day 1) after Tz-TCO gluing. The ratio of cell numbers in the glue pairs after flow for Jurkat-A549 (d) and Jurkat-NIH3T3 (e) cells.

2.4. Shape and bonding efficiency of glued cells

When three groups comprising unmodified control (Hoechst, blue), Tz-modified (CellTracker red), and TCO-modified (CellTracker green) Jurkat T cells were incubated on a nutating mixer for 10 min, only Tz and TCO-modified cells were specifically bound (Figure 3a). Tz- and TCO-modified cells in suspension culture produced not only two-cell pairs (doublet) but also triplets and other multi-cellular clusters comprising three or more cells of opposite click molecules (Figure 3b). Scanning electron microscope (SEM) images revealed a rather close adhesion between cells (Figure 3c). The contact area was 10–15% of the entire cell surface area. Flow cytometry allowed quantitative analysis of the glued cells in large population (~1 million). In controls, only 0.1% cells were double positive, confirming the low rates of non-click attachment events (Figure 3d). The double-positive population was 5.4% when the cells were modified with Tz- and TCO-DBCO at 10 µM. At our protocol concentration of 50 µM, about 46% of the Tz- and TCO-modified cells formed two- or multiple-cell pairs. Increasing the concentration to 100 µM did not much improve the glued cell population.

Figure 3.

Figure 3

Microscopy and cytometry analysis. (a) Fluorescence images of glued Jurkat T cells in suspension. Scale bar, 100 µm. (b) High-resolution image of two-cell doublet and four-cell quartet glued cells (circles). Scale bar, 50 µm. (c) SEM images of doublet (top) and triplet (bottom) glued Jurkat T cells (pseudo colored green and red). Scale bar, 5 µm. Flow cytometry data of Jurkat T cells glued with different concentrations of Tz and TCO (d) or by azide-DBCO click chemistry (e). Inset, a schematic of DBCO-PEG4-DBCO.

We compared our protocol with an alternative bonding method based on azide-DBCO click chemistry (Figure S13 in Supporting Information).[21] The azide-DBCO click chemistry has a reaction rate of k2=0.31 M−1s−1, substantially lower than the typical Tz-TCO reaction rate[22] of k2=820 M−1s−1. Azide-modified Jurkat T cells were treated with homobifunctional crosslinker, DBCO-polyethyleneglycol4-DBCO, at a concentration of 50 µM to produce DBCO-modified cells and these cells were mixed with pristine azide-modified cells. The ratio of the glued cells after incubation for 10 min was measured to be only 4.1% (Figure 3e), much lower than 46% for the Tz-TCO method. Increasing the incubation time did not improve the gluing ratio of azide-DBCO chemistry. Efficiencies of 5.6 and 7.1% were measured with incubation times of 1 and 2 hours, respectively (Figure S14 in supporting information). To analyze the amount of azide, DBCO, Tz, and TCO on A549 cells, we treated the cells with DBCO-Cy3, azide-Cy3, TCO-Cy3, and Tz-Cy3, respectively, and measured the Cy3 fluorescence intensity using microscopy. The measurements showed that the amounts of DBCO and azide were not different from those of Tz and TCO (Figure S15 in Supporting Information). Therefore, we attributed the low gluing efficiency of the control DBCO-modified cells mainly to the low reaction rate of azide-DBCO click chemistry. This result represents the critical role of rapid Tz-TCO click reaction for gluing cells.

2.5. High-throughput imaging cytometry analysis of cell complexes

To analyze the individual population of glued cell groups, we used an imaging cytometry system (Figure 4a), which generates high-speed microscopic images of cells during flow cytometry analysis (Figure 4b). From over 7,000 images of cell groups, the numbers of cells in singlet, doublet, triplet, quartet, and multiple groups (N>4) were counted (Figure 4c,d). We found 29% of the Jurkat T cells remained as singlet, and 43% of cells were in doublet (Figure 4e). Since there are two cells in each doublet, the ratio of doublet to singlet is 0.74 (=21.5/29). 11% of the cells were in triplet, which makes the triplet to single ratio to be 0.13 (=3.7/29). These results indicate that the current protocol is optimized for producing doublets with high yield. Increasing cell concentration during incubation tended to generate more higher-order cell complexes. Forward and side light scattering analysis showed reduced aspect ratios (deviation from spherical shapes) and increased scattering area of the glued-cell samples compared to controls, as expected from their shapes (Figure S13 in Supporting information). The specific ratios of glued cells vary depending on the amount of the Tz or TCO molecules at the cell surface. For EL4 cells, the total ratio of the glued cells was about 19%, 80% of which were in doublet (Figure 4f). The relatively low yield of glued cells for EL4 cells is due to the low amount of sialic acid on the cell surface.

Figure 4.

Figure 4

Analysis of glued cells by imaging cytometry. (a) Illustration showing simultaneous flow cytometry and microscopic imaging. (b) Measured cytometry graph. The population in the box corresponds to glued cells. (c) Cytometry images showing glued population of green-and red-labeled Jurkat T cells after focus filtering. (d) Representative captured images of various cell groups. (e) The measured statistics of various cell groups for the case of Jurkat-Jurkat cells. (f) Statistics for EL4-EL4 cells.

2.6. Glued cells injected into blood circulation in vivo

To investigate the in vivo stability of glue cells, we injected two-color glued, Jurkat T cells (Hoechst and CellTracker Green) into wild-type mice (c57BL/6 strain) by retro-orbital injection while visualizing blood vessels in the intact ear skin by laser-scanning two-photon excitation fluorescence microscopy.[23] Video-rate imaging showed doublet glued cells flowing in the blood vessels, both veins and arteries, within a field of view (Figure 5a). Rapid sequestration of injected cells in the lung capillary beds is well known.[24] Three-color Jurkat T cells, including Hoechst-stained unmodified controls (blue), in equal population (~106 total) were injected intravenously into wild-type mice, and after 20 min the lung tissues were harvested and imaged ex vivo by two-photon fluorescence microscopy. A large number of cells, including single cells, doublet, and higher-order complexes, were found in the lung tissue (Figure 5b). Most of them were trapped within lung capillary beds.[24] About 31% of cells made in contact with other cells consisted of red and green cells (Figure 5c). This ratio was consistent with the population statistics measured in vitro (Figure 4b) and at least six-fold higher than non-specific pairs in contact (Figure 5c). These results show that the majority of glued cells remain attached in the tissue.

Figure 5.

Figure 5

Cells injected into mice. (a) Intravital images of glued Jurkat T cells flowing in the blood vessels of the ear skin. Scale bar, 100 µm. (b) Fluorescence images of Jurkat T cells in lung tissues harvested about 20 min after injection. Scale bar, 100 µm. (c) Measured population of cells in contact in the lung tissues. R, G, and B represent the color of cell: ‘GR’ indicates cell pairs consisting of Tz-modified (green) and TCO-modified (red) cells.

3. Conclusion

We have demonstrated a cell gluing method based on metabolic glycoengineering and double click chemistry. The metabolically introduced azide groups covalently link the click molecules to the cell surface without using biological links, such as antibodies, establishing “all-chemical” binding between cells. Our comparison study between Tz-TCO with azide-DBCO highlights the importance of the fast reaction rate for gluing cells, which allows multivalent bonds to be formed within a finite time of cell-cell contact during incubation. The chemically glued cells are alive and stably bound after one-day incubation in vitro, and able to withstand a shear stress over 20 dyn/cm2, which is higher than typical vessel-wall shear stress levels of 1–6 dyn/cm2 in veins and 15 dyn/cm2 in arteries.[25] The glue strength and the output yield of cell pairs depend on the cell type and increase with to the amount of click molecules on the cell surfaces. Most tumor cell lines overexpress sialic acids.[26] Other strategies, such as amide coupling or lipid insertion, could be also used to introduce Tz or TCO groups onto the cell surface. Intravenously injected cell pairs were found in the blood stream and traffic to various organs including the lung. Delivering cell pairs to other target tissues, such as inflammation sites or tumors, should be possible when specialized homing cells including stem cells or leukocytes are glued as carriers.[3b,27] Our study represents the first demonstration of injection and imaging of glued cells in vivo. The click chemistry-based cell glue with high specificity, fast reaction rate, stability, and biocompatibility, is promising for the development of a wide range of biomedical applications in vivo. Furthermore, the gluing technology demonstrated here may be applied to the adhesion of any cell types onto artificial surfaces treated with click molecules for broad applications in cell-based sciences and engineering.[28]

4. Experimental Section

Materials

Tetrazine-dibenzo cyclootyne (Tz-DBCO), trans-cyclooctene-polyethyleneglycol12-dibenzo cyclootyne (TCO-DBCO), trans-cyclooctene-amine (TCO-amine), and Cy3-tetrazine (Cy3-Tz) were purchased from Click Chemistry Tools (Scottsdale, AZ, USA). Cy3-NHS ester was purchased from Lumiprobe (Florida, USA). Tetraacetylated N-azidoacetyl-d-mannosamine (Ac4ManNAz), CellTracker green CMFDA, CellTracker red CMTPX, CellTracker blue CMAC, Hoechst 33342, Prestoblue™ cell viability reagent, calcein AM, and ethidium homodimer 1, RPMI 1640, DMEM, fetal bovine serum (FBS), antibiotic-antimycotics were purchased from Life technologies (Grand Island, NY, USA). µ-Slide I 0.8 Luer microfluidic chamber was purchased from ibidi GmbH (Munich, Germany). 70-KDa rhodamine-dextran was purchased from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were of analytical grade and used without further purification.

Synthesis of Cy3-TCO

A solution of TCO-Amine HCl salt (2.0 mg, 0.0075 mmol) and TEA (5 µL, 0.036 mmol) in DMF (100 µL) was incubated at room temperature for 5 min. To a reaction mixture, Cy3-NHS ester (5 mg, 0.0068 mmol) solution in DMF (200 µL) was added. Reaction mixture was stirred at ambient temperature for 1 hr. Desired compound was purified using standard HPLC techniques performed on a Waters’ (Milford, MA) liquid chromatography-mass spectrometry (LC-MS) system. For preparative runs, an Atlantis® Prep T3 OBDTM 5 µM column was used (eluents 0.1% TFA (v/ v) in water and MeCN; gradient: 0–1.5 min, 5–100% B; 1.5–2.0 min 100% B). The title compound was purified in 62.5% yield and its identity was confirmed by LC/MS. For LC-ESI-MS analyses, a Waters XTerra® C18 5 µm column was used.

Cell culture

A549 (Human lung adenocarcinoma), Jurkat T (clone E6-1, human T lymphocyte), NIH3T3 (mouse fibroblast), and EL4 (mouse T lymphocyte) were purchased from ATCC (Manassas, VA, USA). A549 and Jurkat T cells were maintained in RPMI1640 medium containing 10% FBS and 1% antibiotic-antimycotics in humidified 5% CO2 atmosphere at 37 °C. DMEM instead of RPMI1640 was used for NIH3T3 and EL4 cells. For fluorescence labeling, cells were stained with CellTracker green CMFDA, CellTracker red CMTPX, or CellTracker blue CMAC for 30 min in serum-free media.

Imaging of Tz or TCO groups on the cell surface

Cells were washed with PBS and incubated with 5 µM Cy3-TCO or Cy3-Tz and 5 µM Hoechst 33342 in serum-free media for 10 min. After washing with PBS, the cells were observed by a microscope (IX51, Olympus, Chelmsford, MA, USA). The intensity of Cy3 fluorescence was analyzed by using ImageJ.

Cell gluing

Cells were grown in full growth media containing 50 µM Ac4ManNAz for 3 days, and and treated with 50 µM Tz-DBCO or TCO-DBCO for 30 min in PBS containing Ca2+ and Mg2+. After washing with PBS, the cells were collected and mixed together at 5 × 105 cells/ml concentration and incubated for 10 min on a nutating mixer (Labnet, NJ, USA).

Cell viability test

2×103 A549 or NIH3T3 cells were seeded on 96 well plates. After 1 day, the cells were treated with Ac4ManNAz and Tz-DBCO or TCO-DBCO, as described above. The cells were then incubated in 90 µl serum-free media with 10 µl Prestoblue™ solution for 2 hours. Then, the fluorescence intensity from the wells was measured at 560-nm excitation and 590-nm emission by using a GEMINI EM microplate reader (Molecular Devices, CA, USA) and its ratio to that from untreated controls determined the cell viability. For calcein AM/ethidium homodimer 1 assay, Jurkat T Cells were stained by Celltracker blue CMAC before treatment of TCO-DBCO and gluing. After gluing, they were incubated in serum-free medium containing 2 µM calcein AM and 4 µM ethidium homodimer 1 for 30 min, and incubated in serum-free medium for 15 min. After washing with PBS, the sample was observed by a microscope (IX51, Olympus, Chelmsford, MA, USA).

Interleukin-2 (IL-2) ELISA

2×104 Tz-modifed A549 cells on 96 well plates were incubated with 5×104 TCO-modified Jurkat T cells for 10 min. After washing away unglued cells with PBS, and remaining cells were stimulated with 10 µg/ml phytohemaglutinin and 1 ng/ml phorbol 12-myristate 13-acetate. After 1 day, supernatants were harvested and the amounts of IL-2 were analyzed by human IL-2 ELISA kit (Thermoscientific, Rochester, USA).

Fluidic chamber study

2×103 A549 or NIH3T3 cells in 200 µl full growth medium were seeded and grown on a µ-Slide I 0.8 Luer fluidic chamber and incubated with Ac4ManNAz and with Tz-DBCO as described above. Then, they were incubated for 10 min with 1×104 TCO-modified or control bare Jurkat T cells in 200 µl serum free RPMI1640 containing 1% w/v BSA on nutating mixer. While applying pre-determined flow rates by using a syringe pump, the cells were observed with a microscope (IX51, Olympus, Chelmsford, MA, USA). The number of the cells per field of view (200 µm by 200 µm) was counted.

Cell migration test

2×105 Tz-modified NIH3T3 cells and 5×105 TCO-modified Jurkat T cells were incubated in a 24 well plate for 10 min. After washing away unglued cells, the center of each well was scratched by using the tip of a 100 µl pipet in a crisscross pattern. The images were obtained by using a microscope (IX51, Olympus, Chelmsford, MA, USA).

SEM imaging

Glued cells were loaded on circular cover glass and stored in ethanol, dried by critical point dryer 931 GL (tousimis, MD, USA) and coated with 5-nm Au by a 300T dual head sputter coater (EMS, PA, USA). The samples were imaged by Evo 55 environmental SEM (Zeiss, Oberkochen, Germany).

Flow cytometry analysis

The glued cells were transferred to a 5 ml polystyrene round bottom tube with cell-strainer cap (mesh size 30 µm, BD bioscience, CT, USA) for filtering, and analyzed by a FACSAria cell sorting system (BD bioscience, CT, USA) or an Amnis ImageStreamX Mark II imaging flow cytometer (Amnis Corporation, WA, USA).

Intravital imaging

All animal experiments were performed in compliance with institutional guidelines and approved by the subcommittee on research animal care at the Harvard Medical School. All experiments used 7- to 14-week-old C57BL/6J mice (Jackson Laboratory). 70-KDa rhodamine-dextran (100 µl of 3 % w/v) was intravenously administered to visualize blood vessels. While imaging the blood vessels in the ear skin of an anesthetized mouse were imaged under a home-built two-photon microscope, glued Jukart T cells stained with Hoechst 33342 and CellTracker Green were administered intravenously (100 µl, 5 × 106 cells/ml). Movies of the flowing cells were captured at 30 Hz for duration of 5 min following the injection. For ex vivo imaging, anesthetized mice were injected intravenously with glued cells stained with CellTracker Red and CellTracker Green (100 µl, 5 × 105 cells/ml). Twenty minutes after injection, the mice were killed, and the lung tissues were harvested, cut into 5 mm by 5 mm slices, put on slide glass, and observed by two-photon microscopy.

Two-photon microscopy

We used a home-built, video-rate, two-photon microscope. The system equipped a mode-locked Ti-Sapphire laser (MaiTai DeepSee eHP, Newport) as an excitation source, which provides ~120 fs width pulses at 80 MHz repetition rate. The scanning unit is composed of a polygon mirror for fast axis (x) and a galvanometer mirror for slow axis (y), allowing a frame rate of 30 Hz. A 20**X 1.0-NA water-immersion objective lens (Olympus) was used for all experiments. The emitted light was detected by three photomultiplier tubes through dichroic and bandpass filters for the blue channel (330–480 nm), green channel (500–550 nm) and red channel (560–670 nm).

Supplementary Material

Small Supplementary

Acknowledgments

The authors thank Danny Cao and Scott Mordecai for help in cytometry. This work was supported in part by the US National Science Foundation (ECCS-1264356), Department of Defense (FA9550-11-1-0331), and Mid-career Researcher Program through the National Research Foundation of Korea (2012R1A2A2A06045773), National IT Industry Promotion Agency (IT Consilience Creative Program, NIPA-2014-H0201-14-1001) and the Medical Discovery Postdoctoral Fellowship Award from MGH.

Contributor Information

Dr. Heebeom Koo, Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, 65 Landsdowne St., UP-5, Cambridge, MA 02139, USA

Dr. Myunghwan Choi, Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, 65 Landsdowne St., UP-5, Cambridge, MA 02139, USA

Dr. Eunha Kim, Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

Prof. Sei Kwang Hahn, Department of Materials Science and Engineering, Pohang University of Science and Technology, Kyungbuk 790-784, Korea

Prof. Ralph Weissleder, Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

Prof. Seok Hyun Yun, Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, 65 Landsdowne St., UP-5, Cambridge, MA 02139, USA

References

  • 1.a) Ahrends R, Ota A, Kovary KM, Kudo T, Park BO, Teruel MN. Science. 2014;344:1384–1389. doi: 10.1126/science.1252079. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Meshel AS, Wei Q, Adelstein RS, Sheetz MP. Nat Cell Biol. 2005;7:157–164. doi: 10.1038/ncb1216. [DOI] [PubMed] [Google Scholar]
  • 2.a) Lee S, Mandic J, Van Vliet KJ. Proceedings of the National Academy of Sciences. 2007;104:9609–9614. doi: 10.1073/pnas.0702668104. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu HL, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S. Cell. 2014;158:1110–1122. doi: 10.1016/j.cell.2014.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.a) Ohashi K, Yokoyama T, Yamato M, Kuge H, Kanehiro H, Tsutsumi M, Amanuma T, Iwata H, Yang J, Okano T, Nakajima Y. Nat. Med. 2007;13:880–885. doi: 10.1038/nm1576. [DOI] [PubMed] [Google Scholar]; b) Karp JM, Leng Teo GS. Cell stem cell. 2009;4:206–216. doi: 10.1016/j.stem.2009.02.001. [DOI] [PubMed] [Google Scholar]
  • 4.a) Gartner ZJ, Bertozzi CR. Proceedings of the National Academy of Sciences. 2009;106:4606–4610. doi: 10.1073/pnas.0900717106. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Todhunter ME, Jee NY, Hughes AJ, Coyle MC, Cerchiari A, Farlow J, Garbe JC, LaBarge MA, Desai TA, Gartner ZJ. Nat Meth. 2015 doi: 10.1038/nmeth.3553. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vogel K, Glettenberg M, Schroeder H, Niemeyer CM. Small. 2013;9:255–262. doi: 10.1002/smll.201201852. [DOI] [PubMed] [Google Scholar]
  • 6.Wang B, Song J, Yuan H, Nie C, Lv F, Liu L, Wang S. Adv. Mater. 2014;26:2371–2375. doi: 10.1002/adma.201304593. [DOI] [PubMed] [Google Scholar]
  • 7.Kim CH, Axup JY, Dubrovska A, Kazane SA, Hutchins BA, Wold ED, Smider VV, Schultz PG. J. Am. Chem. Soc. 2012;134:9918–9921. doi: 10.1021/ja303904e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xiong X, Liu H, Zhao Z, Altman MB, Lopez-Colon D, Yang CJ, Chang L-J, Liu C, Tan W. Angew. Chem. Int. Ed. 2013;52:1472–1476. doi: 10.1002/anie.201207063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Haun JB, Devaraj NK, Hilderbrand SA, Lee H, Weissleder R. Nat Nano. 2010;5:660–665. doi: 10.1038/nnano.2010.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dutta D, Pulsipher A, Luo W, Yousaf MN. J. Am. Chem. Soc. 2011;133:8704–8713. doi: 10.1021/ja2022569. [DOI] [PubMed] [Google Scholar]
  • 11.Kolb HC, Finn MG, Sharpless KB. Angew. Chem. Int. Ed. 2001;40:2004–2021. doi: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  • 12.Jewett JC, Bertozzi CR. Chem. Soc. Rev. 2010;39:1272–1279. doi: 10.1039/b901970g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.a) Shelbourne M, Chen X, Brown T, El-Sagheer AH. Chem. Commun. 2011;47:6257–6259. doi: 10.1039/c1cc10743g. [DOI] [PubMed] [Google Scholar]; b) Wang K, Sachdeva A, Cox DJ, Wilf NW, Lang K, Wallace S, Mehl RA, Chin JW. Nat Chem. 2014;6:393–403. doi: 10.1038/nchem.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Prescher JA, Bertozzi CR. Cell. 2006;126:851–854. doi: 10.1016/j.cell.2006.08.017. [DOI] [PubMed] [Google Scholar]; d) Peterson VM, Castro CM, Lee H, Weissleder R. ACS Nano. 2012;6:3506–3513. doi: 10.1021/nn300536y. [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Colombo M, Sommaruga S, Mazzucchelli S, Polito L, Verderio P, Galeffi P, Corsi F, Tortora P, Prosperi D. Angew. Chem. Int. Ed. 2012;51:496–499. doi: 10.1002/anie.201106775. [DOI] [PubMed] [Google Scholar]; f) Xi W, Scott TF, Kloxin CJ, Bowman CN. Adv. Funct. Mater. 2014;24:2572–2590. [Google Scholar]
  • 14.a) Rossin R, Renart Verkerk P, van den Bosch SM, Vulders RCM, Verel I, Lub J, Robillard MS. Angew. Chem. Int. Ed. 2010;49:3375–3378. doi: 10.1002/anie.200906294. [DOI] [PubMed] [Google Scholar]; b) Laughlin ST, Baskin JM, Amacher SL, Bertozzi CR. Science. 2008;320:664–667. doi: 10.1126/science.1155106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Koo H, Lee S, Na JH, Kim SH, Hahn SK, Choi K, Kwon IC, Jeong SY, Kim K. Angew. Chem. Int. Ed. 2012;51:11836–11840. doi: 10.1002/anie.201206703. [DOI] [PubMed] [Google Scholar]
  • 16.Harada A, Kobayashi R, Takashima Y, Hashidzume A, Yamaguchi H. Nature Chemistry. 2011;3:34–37. doi: 10.1038/nchem.893. [DOI] [PubMed] [Google Scholar]
  • 17.Saxon E, Bertozzi CR. Science. 2000;287:2007–2010. doi: 10.1126/science.287.5460.2007. [DOI] [PubMed] [Google Scholar]
  • 18.Neves AA, Stöckmann H, Wainman YA, Kuo JCH, Fawcett S, Leeper FJ, Brindle KM. Bioconj. Chem. 2013;24:934–941. doi: 10.1021/bc300621n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Guo Y, Rumschlag-Booms E, Wang J, Xiao H, Yu J, Wang J, Guo L, Gao G, Cao Y, Caffrey M, Rong L. Virology Journal. 2009;6:39. doi: 10.1186/1743-422X-6-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Park J, Fan Z, Deng CX. J. Biomech. 2011;44:164–169. doi: 10.1016/j.jbiomech.2010.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.a) Debets MF, van Berkel SS, Dommerholt J, Dirks AJ, Rutjes FPJT, van Delft FL. Acc. Chem. Res. 2011;44:805–815. doi: 10.1021/ar200059z. [DOI] [PubMed] [Google Scholar]; b) Devaraj NK, Weissleder R. Acc. Chem. Res. 2011;44:816–827. doi: 10.1021/ar200037t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Karver MR, Weissleder R, Hilderbrand SA. Bioconj. Chem. 2011;22:2263–2270. doi: 10.1021/bc200295y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sarkar D, Spencer JA, Phillips JA, Zhao W, Schafer S, Spelke DP, Mortensen LJ, Ruiz JP, Vemula PK, Sridharan R, Kumar S, Karnik R, Lin CP, Karp JM. Blood. 2011;118:e184–e191. doi: 10.1182/blood-2010-10-311464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.a) Mitchell MJ, Wayne E, Rana K, Schaffer CB, King MR. Proceedings of the National Academy of Sciences. 2014;111:930–935. doi: 10.1073/pnas.1316312111. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Maldiney T, Bessière A, Seguin J, Teston E, Sharma SK, Viana B, Bos AJJ, Dorenbos P, Bessodes M, Gourier D, Scherman D, Richard C. Nat Mater. 2014;13:418–426. doi: 10.1038/nmat3908. [DOI] [PubMed] [Google Scholar]
  • 25.Barnes JM, Nauseef JT, Henry MD. PLoS One. 2012;7:e50973. doi: 10.1371/journal.pone.0050973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Matsumoto A, Sato N, Kataoka K, Miyahara Y. J. Am. Chem. Soc. 2009;131:12022–12023. doi: 10.1021/ja902964m. [DOI] [PubMed] [Google Scholar]
  • 27.Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, Lowe E, Mahoney DJ, Tammi MI, Kahmann JD, Campbell ID, Day AJ, Jackson DG. Mol. Cell. 2004;13:483–496. doi: 10.1016/s1097-2765(04)00080-2. [DOI] [PubMed] [Google Scholar]
  • 28.a) Yao X, Peng R, Ding J. Advanced Materials. 2013;25:5257–5286. doi: 10.1002/adma.201301762. [DOI] [PubMed] [Google Scholar]; b) Yang F, Williams CG, Wang D-a, Lee H, Manson PN, Elisseeff J. Biomaterials. 2005;26:5991–5998. doi: 10.1016/j.biomaterials.2005.03.018. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Small Supplementary

RESOURCES